| CAM | calf aortic microsome; cell adhesion molecule; cell-associating molecule; chorioallantoic membrane; ... |
|---|---|
| ER | efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re... |
| AMOG | adhesion molecule on glia |
| EARR | extended aortic root replacement |
| EBCDIC | Extended Binary Coded Decimal Interchange Code |
| sVCAM-1 | adhesion molecule 1 , vascular cell adhesion molecule 1 |
|---|---|
| ESBL | Extended Spectrum Beta-Lactamase |
| EXAFS | Extended X-Ray Absorption Fine Structure |
| ER | extended release |
| XR | extended release |
| mastectomy, extended radical | Radical mastectomy with removal of the ipsilateral half of the sternum and a portion of ribs two through five with the underlying pleura and the internal mammary lymph nodes. (12 Dec 1998) |
|---|---|
| contact lenses, extended-wear | Hydrophilic contact lenses worn for an extended period or permanently. (12 Dec 1998) |
| extended clasp | A clasp that extends from its minor connector along the lingual and/or facial surface of two or more teeth. (05 Mar 2000) |
| extended family | A group of persons comprising members of several generations united by blood, adoptive, marital or equivalent ties. (05 Mar 2000) |
| extended family therapy | A type of family therapy that involves family members outside the nuclear family and who are closely associated with it and affect it. (05 Mar 2000) |
| extended insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| extended pyelotomy | Extension of a standard pyelotomy into the lower pole infundibulum through the avascular plane between the posterior and basilar segmental renal arteries. Synonym: Gil-Vernet operation. (05 Mar 2000) |
| extended radical mastectomy | Excision of the entire breast including the nipple, areola, and overlying skin, as well as the pectoral muscles and the lymphatic-bearing tissues of the axilla and chest wall and internal mammary chain of lymph nodes. (05 Mar 2000) |
| vascular cell adhesion molecule-1 | Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (12 Dec 1998) |
| cell adhesion molecule | <molecular biology> Although this could mean any molecule involved in cellular adhesive phenomena, it has acquired a more restricted sense, namely a molecule on the surface of animal tissue cells, antibodies (or Fab fragments) against that specifically inhibit some form of intercellular adhesion. Examples are Liver Cell Adhesion Molecule and Neural Cell Adhesion Molecule, both named from tissues in which first detected, although their occurrence is not in fact restricted to these. Acronym: CAM (26 Nov 1998) |
| repellant guiding molecule | <cell biology> Specific molecules that inhibit the activity of growth cones and are thought to be important in establishing axon pathways during nervous system development. See: growth cone collapse. (18 Nov 1997) |
| gram-molecule | <unit> The amount of a substance with a mass in grams equal to its molecular weight; e.g., a gram-molecule of hydrogen weighs 2.016 g, that of water 18.015 g. (05 Mar 2000) |
| chimeric molecule | A molecule (usually a biopolymer) containing sequences derived from two different genes; specifically, from two different species. Compare: chimera. (05 Mar 2000) |
| molecule | <chemistry> The result of two or more atoms combining by chemical bonding. (09 Oct 1997) |
| hybrid molecule | <molecular biology> A double-stranded nucleic acid molecule which was artificially created from two different single-stranded nucleic acid molecules from different sources, for the purpose of comparing their nucleotide sequences. (09 Oct 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|